Raymond James Financial Inc. Makes New $34.72 Million Investment in Henry Schein, Inc. (NASDAQ:HSIC)

Raymond James Financial Inc. acquired a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 501,734 shares of the company’s stock, valued at approximately $34,720,000.

Several other hedge funds have also recently bought and sold shares of the stock. FMR LLC increased its stake in Henry Schein by 7.8% in the third quarter. FMR LLC now owns 3,280,890 shares of the company’s stock valued at $239,177,000 after acquiring an additional 237,888 shares during the last quarter. Southpoint Capital Advisors LP boosted its position in Henry Schein by 30.0% in the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock valued at $189,540,000 after buying an additional 600,000 shares in the last quarter. Nuance Investments LLC boosted its position in Henry Schein by 22.3% in the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock valued at $166,072,000 after buying an additional 414,748 shares in the last quarter. Clarkston Capital Partners LLC boosted its position in Henry Schein by 5.4% in the third quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock valued at $101,900,000 after buying an additional 71,560 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of Henry Schein by 1.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,191,677 shares of the company’s stock worth $82,464,000 after purchasing an additional 16,616 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Trading Down 0.2 %

Shares of HSIC stock opened at $69.81 on Friday. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.49. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The company has a 50-day simple moving average of $74.78 and a two-hundred day simple moving average of $72.62. The company has a market capitalization of $8.67 billion, a price-to-earnings ratio of 28.73, a PEG ratio of 2.13 and a beta of 0.90.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the previous year, the company posted $0.66 earnings per share. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. Research analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on HSIC. Wells Fargo & Company began coverage on shares of Henry Schein in a report on Friday, February 14th. They set an “equal weight” rating and a $80.00 price target on the stock. UBS Group cut their price target on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, February 26th. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and boosted their target price for the company from $69.00 to $84.00 in a report on Monday, January 6th. Mizuho started coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price on the stock. Finally, Barrington Research restated an “outperform” rating and issued a $90.00 target price on shares of Henry Schein in a report on Wednesday, February 26th. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $81.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.